Anthony J. Polverino
Director/Board Member at BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 13 811 $ as of 29/04/2024
Anthony J. Polverino active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 04/02/2018 | - |
| Independent Dir/Board Member | 04/02/2018 | - |
Career history of Anthony J. Polverino
Former positions of Anthony J. Polverino
| Companies | Position | Start | End |
|---|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 19/09/2018 | 18/01/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 31/12/2014 | 31/12/2017 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Training of Anthony J. Polverino
| University of Adelaide | Undergraduate Degree |
| Flinders University | Doctorate Degree |
Statistics
International
| United States | 4 |
| Australia | 3 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Anthony J. Polverino
- Experience
